Curr Top Microbiol Immunol
Retrieved from Epic Research
Key Takeaways Mechanism of action: Triple-hormone agonist targeting GLP-1, GIP, and glucagon receptors Efficacy: 24.2% average weight loss in 48 weeks UK availability: 2026 (UK), potentially 2027 (FDA) Common side effects: Nausea, diarrhoea, vomiting, constipation Safety profile: Similar to existing GLP-1 medications but with concerns about rapid weight loss By entering I agree to the Terms and Conditions
This guide breaks down exactly what Toujeo is, what GLP-1 medications are, why the confusion happens so frequently, and what the differences mean for anyone navigating diabetes treatment or weight loss with peptide-based therapies
Kidney function tests (creatinine, eGFR) so issues like chronic kidney disease dont go unnoticed